Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Cybin Inc. < Previous 1 2 3 4 5 6 Next > Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities November 23, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Inc. Reports its Second Quarter Financial Results and Recent Business Highlights November 15, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Present at the Jefferies London Healthcare Conference November 11, 2021 From Cybin Inc. Via Business Wire Cybin to Announce Second Quarter FY2021 Financial Results and Business Update on November 15, 2021 November 09, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Positive CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin for Treatment of Mental Health November 08, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Granted DEA Schedule I Manufacturing License November 04, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Hosting Research and Development Briefing on November 8, 2021 November 02, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program October 28, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology October 26, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies October 19, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Files an International Patent Application Covering Psychedelic Delivery Methods October 12, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Additional Adelia Milestone Achievements October 07, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development October 01, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Present at Upcoming Cantor and Benzinga Investor Conferences September 27, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13th September 09, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Additional Adelia Milestone Achievements August 31, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs August 19, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion August 17, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Election of Theresa Firestone as Director, Results of Shareholders’ Meeting and Adoption of Shareholder Rights Plan August 16, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Inc. Announces 2021 First Quarter Financial Results and Business Highlights August 13, 2021 From Cybin Inc. Via Business Wire Tickers CYBN CORRECTING and REPLACING Cybin Announces Additional Adelia Milestone Achievements August 12, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Additional Adelia Milestone Achievements August 12, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Present at Canaccord Genuity’s 41st Annual Growth Conference on August 10th August 09, 2021 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Commence Trading on the NYSE American on August 5 August 04, 2021 From Cybin Inc. Via Business Wire Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5 July 28, 2021 From Cybin Inc. Via Business Wire Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares July 28, 2021 From Cybin Inc. Via Business Wire Cybin Announces Conditional Listing Approval from NYSE American July 21, 2021 From Cybin Inc. Via Business Wire Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy July 13, 2021 From Cybin Inc. Via Business Wire Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th July 09, 2021 From Cybin Inc. Via Business Wire Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio July 08, 2021 From Cybin Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.